[6] In response to an urgent, unmet need for COVID-19 test development and production in the United States,[8][9] Curative rapidly shifted focus in March 2020.

[12][13] The Curative test was designed with a scalable process and opportunities to reduce healthcare worker exposure risk, and therefore the amount of personal protective equipment (PPE) used.

[9][11][15] The United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Curative's SARS-CoV-2 Assay in April 2020.

[citation needed] In Q3 of 2022, Curative began the process of shutting down its COVID-19 testing business while simultaneously launching an employer-based health insurance offering**.

Utilizing a new model for health insurance, the Curative plan has one monthly premium, and there are no additional costs for accessing medical services and most pharmaceuticals within their broad-based physician network and extensive drug formulary*.

[17][21] Curative developed a self-collected oral fluid swab[22] as an alternative sample collection method,[23] an orthogonal supply chain approach[1][24] to avoid competing with other SARS-CoV-2/COVID-19 test kit and laboratory analysis providers,[11][9] created the Curative SARS-CoV-2 Assay, and began field tests using supervised self-collection in Los Angeles and Long Beach (California) in March.

The Curative SARS-CoV-2 Assay were implemented for medical diagnostic programs in the United States, including United States Armed Forces operations,[16][31] prisons,[8][32] state-wide nursing home, long-term care facilities,[33] city-wide centers, regional testing centers,[34][35] state-wide testing programs,[36][37] and airports.

[31] In August, Florida officials signed a contract with Curative to provide COVID-19 testing services for staff at nursing home and long-term care facilities located throughout the state.

[43] The state later decided not to renew the contract following a federal government decision to ship rapid antigen detection test kits directly to facilities.

[19] As of February 2021, the company had partnered with communities in California,[50][51] Delaware,[52] Florida,[53] Massachusetts,[54] Michigan,[55] Pennsylvania,[56][57] and Texas,[58][64] administering over 2,000,000 vaccinations[citation needed] across 170 sites.

[70] '*A Baseline Visit is required of members in order to qualify for no copays and no deductibles for in-network care and preferred prescriptions throughout the calendar year.